AAM
VERA icon

AMI Asset Management’s Vera Therapeutics VERA Stock Holding History

AMI Asset Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Buy
30,582
+8,630
+39% +$322K 0.08% 43
2026
Q1 		$883K Sell
21,952
-6,571
-23% -$283K 0.06% 60
2025
Q4 		$1.44M Buy
+28,523
New +$1.01M 0.08% 45

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AMI Asset Management's VERA Position: Q2 2026 in Review

AMI Asset Management increased its Vera Therapeutics (VERA) stake by 39% in Q2 2026, buying an estimated $322K and bringing the position to 30,582 shares worth $1.31M. The position accounts for 0.08% of the portfolio, ranked #43.

AMI Asset Management first reported a position in VERA in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.44M in Q4 2025. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • AMI Asset Management held 30,582 shares of Vera Therapeutics worth $1.31M as of Q2 2026.
  • AMI Asset Management bought 8,630 Vera Therapeutics shares in Q2 2026, an estimated $322K.
  • Vera Therapeutics made up 0.08% of AMI Asset Management's portfolio in Q2 2026, its #43 holding.
  • AMI Asset Management first reported a position in Vera Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • AMI Asset Management's Vera Therapeutics position peaked at $1.44M in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on AMI Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.